Skip to content

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06574087
Enrollment
248
Registered
2024-08-27
Start date
2023-01-13
Completion date
2027-01-31
Last updated
2025-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Infection, HPV-Related Carcinoma

Keywords

anal cancer, HPV, anal intraepithelial neoplasia

Brief summary

The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.

Interventions

DIAGNOSTIC_TESThrHPV test and cytology

Perfomance of hrHPV test and cytology

Sponsors

Medical University of Gdansk
CollaboratorOTHER
National Science Centre, Poland
CollaboratorOTHER_GOV
PCK Marine Hospital in Gdynia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* HPV related gynecological disease confirmed in histo-pathological examination * the posibility to obtain material from gynecological organ and from anal canal

Design outcomes

Primary

MeasureTime frameDescription
Anal intraepithelial neoplasm/ anal cancerJust before surgeryNumber of Participants with anal intraepithelial neoplasm/ anal cancer among patients with HPV-related gynecological diseases.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026